AR and prostate carcinoma: Not only can the pro-inflammatory signals associated with activated (“M1”) macrophages contribute to prostate cancer through enhanced proliferation and aggressiveness, anti-inflammatory cytokines (like IL-4) associated with alternatively activated (“M2”) macrophages can also contribute to pathology by activating AR signaling [191].